Women's Health

Watson-Brown welcomed the PBS listings but questioned why other measures were delayed until after the election. Watson-Brown argued that the Greens had costed policies to make contraceptives and menopausal hormone therapies free, similar to systems in other countries. Watson-Brown criticised the government for failing to tackle the cost and availability of surgical abortions, particularly in rural areas. Watson-Brown warned against potential restrictions on reproductive rights under a future minority government.

Claydon described the investment as a historic boost that addresses long-standing barriers to women's health care. Claydon noted that peak medical bodies had praised the package for lowering costs and increasing choice. Claydon highlighted that new contraceptive pills would save women hundreds of dollars annually and that Medicare rebates for IUDs would increase significantly. Claydon linked the policy to the broader agenda of a majority-women government to ensure equity and fair opportunity.

Payne argued that the investment corrects systemic neglect of women's health issues such as endometriosis and menopause. Payne detailed the benefits of new PBS listings for Yaz and Yasmin, which would save 50,000 women money annually. Payne also noted the establishment of 11 new endometriosis clinics and improved access to pharmacist-led treatment for urinary tract infections. Payne emphasised that the package provides women with greater agency over their reproductive health and reduces financial burdens.